{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T12:58:02Z","timestamp":1790945882942,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd014542","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000}}],"reference-count":86,"publisher":"Wiley","issue":"8","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd014542.pub2","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T10:52:43Z","timestamp":1786445563000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Subcutaneous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy"],"prefix":"10.1002","volume":"2026","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4446-1362","authenticated-orcid":false,"given":"Sander RM","family":"Bus","sequence":"additional","affiliation":[{"name":"Department of Neurology, Amsterdam Neuroscience; Amsterdam UMC, University of Amsterdam; Amsterdam Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2522-4081","authenticated-orcid":false,"given":"Luuk","family":"Wieske","sequence":"additional","affiliation":[{"name":"Department of Neurology, Amsterdam Neuroscience; Amsterdam UMC, University of Amsterdam; Amsterdam Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2102-6053","authenticated-orcid":false,"given":"Stephen","family":"Keddie","sequence":"additional","affiliation":[{"name":"Department of Neurology; The Royal London Hospital, Barts Healthcare Trust; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivo N","family":"van Schaik","sequence":"additional","affiliation":[{"name":"Department of Neurology, Amsterdam Neuroscience; Amsterdam UMC, University of Amsterdam; Amsterdam Netherlands"},{"name":"Sanquin Blood Supply Foundation; Amsterdam Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0146-0776","authenticated-orcid":false,"given":"Filip","family":"Eftimov","sequence":"additional","affiliation":[{"name":"Department of Neurology, Amsterdam Neuroscience; Amsterdam UMC, University of Amsterdam; Amsterdam Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,8,11]]},"reference":[{"issue":"3","key":"10.1002\/14651858.CD014542.pub2-BIB0001|cit1","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1111\/jns.12573","article-title":"Hyaluronidase-facilitated subcutaneous immunoglobulin 10% as maintenance therapy for chronic inflammatory demyelinating polyradiculoneuropathy: The ADVANCE-CIDP 1 randomized controlled trial","volume":"28","author":"Bril","year":"2023","journal-title":"Journal of the Peripheral Nervous System"},{"issue":"5","key":"10.1002\/14651858.CD014542.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/ene.12080","article-title":"Subcutaneous immunoglobulin in responders to intravenous therapy with chronic inflammatory demyelinating polyradiculoneuropathy","volume":"20","author":"Markvardsen","year":"2013","journal-title":"European Journal of Neurology"},{"issue":"2","key":"10.1002\/14651858.CD014542.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/ene.13218","article-title":"Subcutaneous immunoglobulin as first-line therapy in treatment-naive patients with chronic inflammatory demyelinating polyneuropathy: randomized controlled trial study","volume":"24","author":"Markvardsen","year":"2017","journal-title":"European Journal of Neurology"},{"issue":"1","key":"10.1002\/14651858.CD014542.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1474-4422(17)30378-2","article-title":"Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"17","author":"Schaik","year":"2018","journal-title":"Lancet Neurology"},{"issue":"5","key":"10.1002\/14651858.CD014542.pub2-BIB0005|cit5","doi-asserted-by":"publisher","first-page":"787","DOI":"10.3233\/JND-221615","article-title":"Standardized tapering off subcutaneous immunoglobulin in chronic inflammatory demyelinating polyneuropathy","volume":"10","author":"Markvardsen","year":"2023","journal-title":"Journal of Neuromuscular Disorders"},{"key":"10.1002\/14651858.CD014542.pub2-BIB0006|cit6","unstructured":"Long-term tolerability and safety of HYQVIA\/\u200bHyQvia in CIDP https:\/\/clinicaltrials.gov\/study\/NCT02955355"},{"key":"10.1002\/14651858.CD014542.pub2-BIB0007|cit7","unstructured":"Subcutaneous Immunoglobulin in De-novo CIDP (SIDEC) (SIDEC) https:\/\/clinicaltrials.gov\/study\/NCT04589299"},{"issue":"5","key":"10.1002\/14651858.CD014542.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1212\/WNL.41.5.617","article-title":"Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Report from an Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force","volume":"41","author":"Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force","year":"1991","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD014542.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jns.2016.08.034","article-title":"Disease activity in chronic inflammatory demyelinating polyneuropathy","volume":"369","author":"Albulaihe","year":"2016","journal-title":"Journal of the Neurological Sciences"},{"issue":"6","key":"10.1002\/14651858.CD014542.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1212\/WNL.0000000000001833","article-title":"CIDP diagnostic pitfalls and perception of treatment benefit","volume":"85","author":"Allen","year":"2015","journal-title":"Neurology"},{"issue":"6","key":"10.1002\/14651858.CD014542.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/ACI.0000000000000116","article-title":"Mechanisms of immune regulation by IVIG","volume":"14","author":"Ballow","year":"2014","journal-title":"Current Opinion in Allergy and Clinical Immunology"},{"issue":"8","key":"10.1002\/14651858.CD014542.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1001\/archneur.1989.00520440064022","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy. Clinical characteristics, course, and recommendations for diagnostic criteria","volume":"46","author":"Barohn","year":"1989","journal-title":"Archives of Neurology"},{"issue":"1","key":"10.1002\/14651858.CD014542.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"55","DOI":"10.7326\/0003-4819-93-1-55","article-title":"Immunoglobulin replacement therapy by slow subcutaneous infusion","volume":"93","author":"Berger","year":"1980","journal-title":"Annals of Internal Medicine"},{"issue":"1","key":"10.1002\/14651858.CD014542.pub2-BIB0014|cit14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clim.2004.02.002","article-title":"Subcutaneous immunoglobulin replacement in primary immunodeficiencies","volume":"112","author":"Berger","year":"2004","journal-title":"Clinical Immunology"},{"issue":"2","key":"10.1002\/14651858.CD014542.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.clim.2011.01.006","article-title":"Pharmacokinetics of subcutaneous immunoglobulin and their use in dosing of replacement therapy in patients with primary immunodeficiencies","volume":"139","author":"Berger","year":"2011","journal-title":"Clinical Immunology"},{"issue":"5","key":"10.1002\/14651858.CD014542.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1007\/s10875-013-9876-3","article-title":"Bioavailability of IgG administered by the subcutaneous route","volume":"33","author":"Berger","year":"2013","journal-title":"Journal of Clinical Immunology"},{"issue":"3-4","key":"10.1002\/14651858.CD014542.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000494291","article-title":"Incidence and prevalence of chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review and meta-analysis","volume":"52","author":"Broers","year":"2019","journal-title":"Neuroepidemiology"},{"issue":"2","key":"10.1002\/14651858.CD014542.pub2-BIB0018|cit18","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001797.pub4","article-title":"Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy","author":"Bus","year":"2024","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"12","key":"10.1002\/14651858.CD014542.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1136\/jnnp.2007.114868","article-title":"Idiopathic chronic inflammatory demyelinating polyneuropathy: an epidemiological study in Italy","volume":"78","author":"Chi\u00f2","year":"2007","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"issue":"11","key":"10.1002\/14651858.CD014542.pub2-BIB0020|cit20","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1007\/s10072-013-1426-5","article-title":"Improvement of quality of life in patients with chronic inflammatory demyelinating polyneuropathy shifting from 16 to 20% subcutaneous immunoglobulins","volume":"34","author":"Cocito","year":"2013","journal-title":"Neurological Sciences"},{"issue":"11","key":"10.1002\/14651858.CD014542.pub2-BIB0021|cit21","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1007\/s00415-014-7444-2","article-title":"Subcutaneous immunoglobulin in CIDP and MMN: a short-term nationwide study","volume":"261","author":"Cocito","year":"2014","journal-title":"Journal of Neurology"},{"issue":"7","key":"10.1002\/14651858.CD014542.pub2-BIB0022|cit22","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1136\/jnnp-2014-310280","article-title":"Subcutaneous immunoglobulin in CIDP and MMN: a different long-term clinical response?","volume":"87","author":"Cocito","year":"2016","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"key":"10.1002\/14651858.CD014542.pub2-BIB0023|cit23","volume-title":"Statistical Power Analysis in the Behavioral Sciences","author":"Cohen","year":"1988"},{"issue":"12 Suppl 6","key":"10.1002\/14651858.CD014542.pub2-BIB0024|cit24","first-page":"S13","article-title":"Mechanisms of action of IVIg and therapeutic considerations in the treatment of acute and chronic demyelinating neuropathies","volume":"59","author":"Dalakas","year":"2002","journal-title":"Neurology"},{"issue":"2","key":"10.1002\/14651858.CD014542.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1161\/01.STR.24.2.320","article-title":"Measuring quality of life in stroke","volume":"24","author":"De Haan","year":"1993","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD014542.pub2-BIB0026|cit26","unstructured":"Deeks JJ Higgins JP Altman DG Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.1 (updated September 2020). Cochrane, 2020 Available from https:\/\/www.cochrane.org\/authors\/handbooks-and-manuals\/handbook\/archive\/v6.1"},{"issue":"2","key":"10.1002\/14651858.CD014542.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1136\/jnnp-2018-318714","article-title":"Atypical CIDP: diagnostic criteria, progression and treatment response. Data from the Italian CIDP Database","volume":"90","author":"Doneddu","year":"2019","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"issue":"23","key":"10.1002\/14651858.CD014542.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1212\/WNL.0000000000001044","article-title":"Changing outcome in inflammatory neuropathies: Rasch-comparative responsiveness","volume":"83","author":"Draak","year":"2014","journal-title":"Neurology"},{"issue":"3","key":"10.1002\/14651858.CD014542.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/jns.12126","article-title":"Grip strength comparison in immune-mediated neuropathies: Vigorimeter vs. Jamar","volume":"20","author":"Draak","year":"2015","journal-title":"Journal of the Peripheral Nervous System"},{"key":"10.1002\/14651858.CD014542.pub2-BIB0030|cit30","first-page":"1498-17","volume-title":"Peripheral Neuropathy","author":"Dyck","year":"1993"},{"issue":"14","key":"10.1002\/14651858.CD014542.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1212\/WNL.0b013e31824e8f84","article-title":"Long-term remission of CIDP after pulsed dexamethasone or short-term prednisolone treatment","volume":"78","author":"Eftimov","year":"2012","journal-title":"Neurology"},{"issue":"5","key":"10.1002\/14651858.CD014542.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/WCO.0b013e328363bfa4","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy: update on clinical features, phenotypes and treatment options","volume":"26","author":"Eftimov","year":"2013","journal-title":"Current Opinion in Neurology"},{"issue":"10","key":"10.1002\/14651858.CD014542.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1212\/WNL.0b013e3182494d66","article-title":"Autonomic dysfunction in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"78","author":"Figueroa","year":"2012","journal-title":"Neurology"},{"issue":"8760","key":"10.1002\/14651858.CD014542.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/0140-6736(91)90147-H","article-title":"Home treatment of hypogammaglobulinaemia with subcutaneous gammaglobulin by rapid infusion","volume":"338","author":"Gardulf","year":"1991","journal-title":"Lancet"},{"issue":"21","key":"10.1002\/14651858.CD014542.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1056\/NEJMra1009433","article-title":"Intravenous immune globulin in autoimmune and inflammatory diseases","volume":"367","author":"Gelfand","year":"2012","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD014542.pub2-BIB0036|cit36","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1212\/wnl.48.2.321","article-title":"Chronic inflammatory demyelinating polyneuropathy: clinical features and response to treatment in 67 consecutive patients with and without a monoclonal gammopathy","volume":"48","author":"Gorson","year":"1997","journal-title":"Neurology"},{"issue":"4","key":"10.1002\/14651858.CD014542.pub2-BIB0037|cit37","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1111\/j.1529-8027.2010.00284.x","article-title":"Chronic inflammatory demyelinating polyneuropathy disease activity status: recommendations for clinical research standards and use in clinical practice","volume":"15","author":"Gorson","year":"2010","journal-title":"Journal of the Peripheral Nervous System"},{"key":"10.1002\/14651858.CD014542.pub2-BIB0038|cit38","unstructured":"GRADEpro GDT McMaster University (developed by Evidence Prime)"},{"issue":"1","key":"10.1002\/14651858.CD014542.pub2-BIB0039|cit39","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1177\/1756285614563056","article-title":"Switch from intravenous to subcutaneous immunoglobulin in CIDP and MMN: improved tolerability and patient satisfaction","volume":"8","author":"Hadden","year":"2015","journal-title":"Therapeutic Advances in Neurological Disorders"},{"issue":"1","key":"10.1002\/14651858.CD014542.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00421-011-1975-3","article-title":"Maximal isokinetic and isometric muscle strength of major muscle groups related to age, body mass, height, and sex in 178 healthy subjects","volume":"112","author":"Harbo","year":"2012","journal-title":"European Journal of Applied Physiology"},{"issue":"1","key":"10.1002\/14651858.CD014542.pub2-BIB0041|cit41","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1111\/ene.14056","article-title":"Patient-reported outcomes with subcutaneous immunoglobulin in chronic inflammatory demyelinating polyneuropathy: the PATH study","volume":"27","author":"Hartung","year":"2020","journal-title":"European Journal of Neurology"},{"key":"10.1002\/14651858.CD014542.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jocn.2018.01.018","article-title":"Outcome in chronic inflammatory demyelinating polyneuropathy from a Malaysian centre over sixteen years","volume":"50","author":"Hiew","year":"2018","journal-title":"Journal of Clinical Neuroscience"},{"key":"10.1002\/14651858.CD014542.pub2-BIB0043|cit43","unstructured":"Higgins JP Altman DG Sterne JA Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from https:\/\/www.cochrane.org\/authors\/handbooks-and-manuals\/handbook\/archive\/v5.1.0"},{"key":"10.1002\/14651858.CD014542.pub2-BIB0044|cit44","unstructured":"Higgins JP Eldridge S Li T Chapter 23: Including variants on randomized trials. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.1 (updated September 2020). Cochrane, 2020 Available from https:\/\/www.cochrane.org\/authors\/handbooks-and-manuals\/handbook\/archive\/v6.1"},{"issue":"4","key":"10.1002\/14651858.CD014542.pub2-BIB0045|cit45","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1111\/j.1468-1331.2006.01278.x","article-title":"European Federation of Neurological Societies\/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society","volume":"13","author":"Hughes","year":"2006","journal-title":"European Journal of Neurology"},{"issue":"2","key":"10.1002\/14651858.CD014542.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S1474-4422(07)70329-0","article-title":"Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial","volume":"7","author":"Hughes","year":"2008","journal-title":"Lancet Neurology"},{"issue":"10","key":"10.1002\/14651858.CD014542.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1056\/NEJMra993360","article-title":"Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin","volume":"345","author":"Kazatchkine","year":"2001","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD014542.pub2-BIB0048|cit48","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1007\/s10875-006-9031-5","article-title":"Patients' attitude to subcutaneous immunoglobulin substitution as home therapy","volume":"26","author":"Kittner","year":"2006","journal-title":"Journal of Clinical Immunology"},{"issue":"4","key":"10.1002\/14651858.CD014542.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1529-8027.2009.00243.x","article-title":"Recurrences, vaccinations and long-term symptoms in GBS and CIDP","volume":"14","author":"Kuitwaard","year":"2009","journal-title":"Journal of the Peripheral Nervous System"},{"issue":"12","key":"10.1002\/14651858.CD014542.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1136\/jnnp-2014-309042","article-title":"Intravenous immunoglobulin response in treatment-naive chronic inflammatory demyelinating polyradiculoneuropathy","volume":"86","author":"Kuitwaard","year":"2015","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD014542.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1212\/WNL.0b013e3181aaea47","article-title":"Incidence and prevalence of CIDP and the association of diabetes mellitus","volume":"73","author":"Laughlin","year":"2009","journal-title":"Neurology"},{"issue":"7","key":"10.1002\/14651858.CD014542.pub2-BIB0052|cit52","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1007\/s10072-014-1632-9","article-title":"Subcutaneous vs intravenous administration of immunoglobulin in chronic inflammatory demyelinating polyneuropathy: an Italian cost-minimization analysis","volume":"35","author":"Lazzaro","year":"2014","journal-title":"Neurological Sciences"},{"key":"10.1002\/14651858.CD014542.pub2-BIB0053|cit53","unstructured":"Lefebvre C Glanville J Briscoe S Featherstone R Littlewood A Searching for and selecting studies (chapter last updated March 2025). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5.1 Cochrane, 2025 Available from https:\/\/www.cochrane.org\/handbook"},{"issue":"5","key":"10.1002\/14651858.CD014542.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1136\/jnnp.66.5.677","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy: a prevalence study in south east England","volume":"66","author":"Lunn","year":"1999","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD014542.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/ene.12190","article-title":"Epidemiology of chronic inflammatory neuropathies in southeast England","volume":"21","author":"Mahdi-Rogers","year":"2014","journal-title":"European Journal of Neurology"},{"issue":"5","key":"10.1002\/14651858.CD014542.pub2-BIB0056|cit56","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003280.pub5","article-title":"Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy","author":"Mahdi-Rogers","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD014542.pub2-BIB0057|cit57","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s41669-023-00386-2","article-title":"A budget impact model of maintenance treatment of chronic inflammatory demyelinating polyneuropathy with IgPro20 (Hizentra) relative to intravenous immunoglobulin in the United States","volume":"7","author":"Mallick","year":"2023","journal-title":"PharmacoEconomics Open"},{"issue":"12","key":"10.1002\/14651858.CD014542.pub2-BIB0058|cit58","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1111\/ene.12513","article-title":"Subcutaneous immunoglobulin preserves muscle strength in chronic inflammatory demyelinating polyneuropathy","volume":"21","author":"Markvardsen","year":"2014","journal-title":"European Journal of Neurology"},{"issue":"6","key":"10.1002\/14651858.CD014542.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/bcpt.12428","article-title":"Headache and nausea after treatment with high-dose subcutaneous versus intravenous immunoglobulin","volume":"117","author":"Markvardsen","year":"2015","journal-title":"Basic & Clinical Pharmacology & Toxicology"},{"issue":"2","key":"10.1002\/14651858.CD014542.pub2-BIB0060|cit60","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1111\/ene.13218","article-title":"Subcutaneous immunoglobulin as first-line therapy in treatment-naive patients with chronic inflammatory demyelinating polyneuropathy: randomized controlled trial study","volume":"24","author":"Markvardsen","year":"2017","journal-title":"European Journal of Neurology"},{"issue":"9","key":"10.1002\/14651858.CD014542.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1136\/jnnp-2014-309697","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype","volume":"86","author":"Mathey","year":"2015","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD014542.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1002\/1531-8249(199912)46:6<910::AID-ANA14>3.0.CO;2-2","article-title":"Prevalence of chronic inflammatory demyelinating polyneuropathy in New South Wales, Australia","volume":"46","author":"McLeod","year":"1999","journal-title":"Annals of Neurology"},{"issue":"5","key":"10.1002\/14651858.CD014542.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1136\/jnnp.72.5.596","article-title":"Clinimetric evaluation of a new overall disability scale in immune mediated polyneuropathies","volume":"72","author":"Merkies","year":"2002","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"issue":"11","key":"10.1002\/14651858.CD014542.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1136\/jnnp.2009.194324","article-title":"Confirming the efficacy of intravenous immunoglobulin in CIDP through minimum clinically important differences: shifting from statistical significance to clinical relevance","volume":"81","author":"Merkies","year":"2010","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD014542.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1136\/jnnp.62.4.388","article-title":"Pulsed high dose dexamethasone treatment in chronic inflammatory demyelinating polyneuropathy: a pilot study","volume":"62","author":"Molenaar","year":"1997","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD014542.pub2-BIB0066|cit66","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s10875-006-8905-x","article-title":"Health-related quality of life and treatment satisfaction in North American patients with primary immunedeficiency diseases receiving subcutaneous IgG self-infusions at home","volume":"26","author":"Nicolay","year":"2006","journal-title":"Journal of Clinical Immunology"},{"issue":"1","key":"10.1002\/14651858.CD014542.pub2-BIB0067|cit67","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010369.pub2","article-title":"Treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): an overview of systematic reviews","author":"Oaklander","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD014542.pub2-BIB0068|cit68","doi-asserted-by":"publisher","first-page":"n21","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"3","key":"10.1002\/14651858.CD014542.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/jns5.12038","article-title":"Impairment and disability in 20 CIDP patients according to disease activity status","volume":"18","author":"Panaite","year":"2013","journal-title":"Journal of the Peripheral Nervous System"},{"issue":"3","key":"10.1002\/14651858.CD014542.pub2-BIB0070|cit70","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1111\/cei.12694","article-title":"Facilitated subcutaneous immunoglobulin (fSCIg) therapy \u2013 practical considerations","volume":"182","author":"Ponsford","year":"2015","journal-title":"Clinical & Experimental Immunology"},{"issue":"6","key":"10.1002\/14651858.CD014542.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1002\/mus.23843","article-title":"Long-term outcome in chronic inflammatory demyelinating polyneuropathy patients treated with intravenous immunoglobulin: a retrospective study","volume":"48","author":"Querol","year":"2013","journal-title":"Muscle & Nerve"},{"issue":"6","key":"10.1002\/14651858.CD014542.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/mus.25409","article-title":"Subcutaneous versus intravenous immunoglobulin for chronic autoimmune neuropathies: a meta-analysis","volume":"55","author":"Racosta","year":"2017","journal-title":"Muscle & Nerve"},{"key":"10.1002\/14651858.CD014542.pub2-BIB0073|cit73","unstructured":"Review Manager (RevMan) The Cochrane Collaboration 2024"},{"issue":"9","key":"10.1002\/14651858.CD014542.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1007\/s004150170093","article-title":"Pure motor chronic inflammatory demyelinating polyneuropathy","volume":"248","author":"Sabatelli","year":"2001","journal-title":"Journal of Neurology"},{"issue":"11","key":"10.1002\/14651858.CD014542.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1136\/jnnp-2012-303013","article-title":"Tremor in inflammatory neuropathies","volume":"84","author":"Saifee","year":"2013","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"key":"10.1002\/14651858.CD014542.pub2-BIB0076|cit76","unstructured":"Sch\u00fcnemann HJ Higgins JP Vist GE Glasziou P Akl EA Skoetz N Chapter 14: Completing 'Summary of findings' tables and grading the certainty of the evidence. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 6.1 (updated September 2020). Cochrane, 2020 Available from https:\/\/www.cochrane.org\/authors\/handbooks-and-manuals\/handbook\/archive\/v6.1"},{"key":"10.1002\/14651858.CD014542.pub2-BIB0077|cit77","unstructured":"Sch\u00fcnemann HJ Vist GE Higgins JP Santesso N Deeks JJ Glasziou P Chapter 15: Interpreting results and drawing conclusions. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.1 (updated September 2020). Cochrane, 2020 Available from https:\/\/www.cochrane.org\/authors\/handbooks-and-manuals\/handbook\/archive\/v6.1"},{"issue":"3","key":"10.1002\/14651858.CD014542.pub2-BIB0078|cit78","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/j.1468-1331.2009.02930.x","article-title":"European Federation of Neurological Societies\/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society - first revision","volume":"17","author":"Van den Bergh","year":"2010","journal-title":"European Journal of Neurology"},{"issue":"11","key":"10.1002\/14651858.CD014542.pub2-BIB0079|cit79","doi-asserted-by":"publisher","first-page":"3556","DOI":"10.1111\/ene.14959","article-title":"European Academy of Neurology\/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force-Second revision","volume":"28","author":"Van den Bergh","year":"2021","journal-title":"European Journal of Neurology"},{"issue":"4","key":"10.1002\/14651858.CD014542.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1212\/WNL.0b013e318208824b","article-title":"Rasch-built Overall Disability Scale (R-ODS) for immune-mediated peripheral neuropathies","volume":"76","author":"Van Nes","year":"2011","journal-title":"Neurology"},{"issue":"5","key":"10.1002\/14651858.CD014542.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1111\/j.1468-1331.2012.03851.x","article-title":"Vigorimeter grip strength in CIDP: a responsive tool that rapidly measures the effect of IVIG \u2013 the ICE study","volume":"20","author":"Vanhoutte","year":"2013","journal-title":"European Journal of Neurology"},{"issue":"5","key":"10.1002\/14651858.CD014542.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/clpt.2008.170","article-title":"Monoclonal antibody pharmacokinetics and pharmacodynamics","volume":"84","author":"Wang","year":"2008","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"4","key":"10.1002\/14651858.CD014542.pub2-BIB0083|cit83","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.jaci.2012.06.021","article-title":"Recombinant human hyaluronidase-facilitated subcutaneous infusion of human immunoglobulins for primary immunodeficiency","volume":"130","author":"Wasserman","year":"2012","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"1","key":"10.1002\/14651858.CD014542.pub2-BIB0084|cit84","first-page":"43","article-title":"Appropriate uses of human immunoglobulin in clinical practice: memorandum from an IUIS\/WHO meeting","volume":"60","author":"World Health Organization","year":"1982","journal-title":"Bulletin of the World Health Organization"},{"issue":"4","key":"10.1002\/14651858.CD014542.pub2-BIB0085|cit85","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1177\/1756285615584739","article-title":"Subcutaneous immunoglobulin in treating inflammatory neuromuscular disorders","volume":"8","author":"Yoon","year":"2015","journal-title":"Therapeutic Advances in Neurological Disorders"},{"issue":"10","key":"10.1002\/14651858.CD014542.pub2-BIB0086|cit86","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD014542","article-title":"Subcutaneous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy","author":"Bus","year":"2021","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T12:46:25Z","timestamp":1790945185000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD014542.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Central Editorial Service","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,8,11]]},"references-count":86,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd014542.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,11]]}}}